Bafna Pharmaceuticals Ltd (BAFNAPH)


📊 End of Day Bhavcopy

Date: 2025-09-09

Price: 99.85
% Change: 0.86% (Prev Close: 99.00)

Volume: 13,815
% Change: 91.85% (Prev Volume: 7,201)

Delivery: 9,797
Delivery % : 70.92
% Change: 182.50% (Prev Delivery: 3,468)

Turnover: 14 Lacs
% Change: 93.76% (Prev Turnover: 7)

💹 EOD Valuation

P/E Ratio: 28.53
P/B Ratio: 2.79
Market Cap: 237 Rs. Cr.


Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: BAFNAPH
Market Cap: 246 Rs. Cr.
Face Value: 10.00 Rs.

52 Week High: 116.69
52 Week Low: 67.80

All-Time High: 233.55 Rs.
All-Time Low: 3.55 Rs.


Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
21.18% | 39.28% | 25.80% | 28.71% | -3.31%


👥 Shareholding Pattern

Promoter Holding

Promoter Holding: 75.00%

Change (3Y | 1Y): -15.12% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 9.34%

Change (3Y | 1Y): 9.34% | 0.81%

DII Holding

DII Holding: 0.00%

Change (3Y | 1Y): 0.00% | 0.00%

Public Holding: 15.66%


🏦 Financial Strength

Debt to Equity: 0.33
Debt: 28.20 Rs. Cr.

Book Value: 35.85 Rs.
Current Ratio: 1.63
Interest Coverage: 4.36
Free Cash Flow: 0.34 Rs. Cr.


📈 Growth & Sales

Sales Growth: 2.35%

Sales Growth Qtr (YOY | QoQ):
4.00% | -11.37%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
27.99% | 19.66% | 2.35%


💰 Profit & Earnings

Profit Growth %

Profit Growth: 1498.41%

Profit Growth Qtr (YOY | QoQ):
1016.22% | 158.78%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
40.15% | -4.79% | 1498.41%


EPS Rs.

EPS (TTM): 3.50 Rs.

EPS Qtr (Last Year | Latest):
-0.30 Rs. | 1.43 Rs.

EPS Annual (Last Annual | Annual March):
3.11 Rs. | 1.75 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
18.54% | -4.79%


Net Profit Rs. Cr.

Net Profit (TTM): 8.27 Rs. Cr.

Net Profit (Annual - March): 4.15 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
-0.72| 1.31 | 3.39


EBITDA Rs. Cr.

EBITDA (Quarter): 5.67 Rs. Cr.
EBITDA (Previous Yr Ql): 1.72 Rs. Cr.

EBITDA (Annual - March): 13.99 Rs. Cr.
EBITDA (Previous Annual): 14.56 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
56.50% | 0.80%


📊 Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 10.21%

OPM Qtr (Previous | Current):
7.96% | 14.64%

OPM Annual (5 Yrs | Last Yr | March):
10.58% | 7.29% | 7.71%


Return on Equity %

ROE: 7.69%

ROE (5 Yrs | 3 Yrs | Last Yr):
11.15% | 10.89% | 9.44%


Return on Capital Employed %

ROCE: 8.34%

ROCE (5 Yrs | 3 Yrs | Last Yr):
11.08% | 11.24% | 9.48%


Return on Assets %

ROA (TTM): 4.24%

ROA (5 Yrs | 3 Yrs | Last Yr):
7.08% | 6.54% | 5.25%



PEG Ratio: -5.09
Dividend Yield: 0.00%

PE 3 Yrs: 36.89
PE 5 Yrs: 35.79

Dividend Yield: 0.00%


👥 Company

Bafna Pharmaceuticals Ltd

BAFNAPH

Promoter Holding: %